Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 863 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Regeneca recalls specific lot of RegenArouse

Tadalafil is an FDA-approved drug used as treatment for male erectile dysfunction (ED). The active drug ingredient is not listed on the label for these products. Tadafil could

Insmed plans to begin Arikace study this year

In addition, the company is also planning European registration Phase 3 clinical trial of Arikace in Cystic Fibrosis (CF) patients with Pseudomonas aeruginosa (Pa) lung infections. The randomized